Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity
暂无分享,去创建一个
S. Kaul | R. Wadhwa | J. Dhanjal | D. Sundar | Vipul Kumar
[1] Y. Ahn,et al. Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds , 2020 .
[2] Kemal Yelekçi,et al. Homology modeling and in silico design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes , 2020, Journal of biomolecular structure & dynamics.
[3] G. Gyebi,et al. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants , 2020, Journal of biomolecular structure & dynamics.
[4] Ramesh Chandra,et al. Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures , 2020, Journal of biomolecular structure & dynamics.
[5] Tuğba Taşkın Tok,et al. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2 , 2020, Journal of biomolecular structure & dynamics.
[6] Naún Lobo-Galo,et al. FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication , 2020, Journal of biomolecular structure & dynamics.
[7] Said Ghalem,et al. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria , 2020, Journal of biomolecular structure & dynamics.
[8] Chandrabose Selvaraj,et al. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target , 2020, Journal of biomolecular structure & dynamics.
[9] S. Sinha,et al. An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets , 2020, Journal of biomolecular structure & dynamics.
[10] Sumra Wajid Abbasi,et al. Stilbene-based natural compounds as promising drug candidates against COVID-19 , 2020, Journal of biomolecular structure & dynamics.
[11] Nizam Uddin,et al. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2 , 2020, Journal of biomolecular structure & dynamics.
[12] A. Elfiky,et al. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective , 2020, Journal of biomolecular structure & dynamics.
[13] Ashok P. Giri,et al. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease , 2020, Journal of biomolecular structure & dynamics.
[14] Jerrine Joseph,et al. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach , 2020, Journal of biomolecular structure & dynamics.
[15] M. Bouachrine,et al. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations , 2020, Journal of biomolecular structure & dynamics.
[16] Adolfo B Poma,et al. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment , 2020, Journal of biomolecular structure & dynamics.
[17] Kemal Yelekçi,et al. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes , 2020, Journal of biomolecular structure & dynamics.
[18] Hemant Kumar Srivastava,et al. Peptide-like and small-molecule inhibitors against Covid-19 , 2020, Journal of biomolecular structure & dynamics.
[19] Sourav Das,et al. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study , 2020, Journal of biomolecular structure & dynamics.
[20] Majid Sharifi,et al. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin , 2020, Journal of biomolecular structure & dynamics.
[21] Hualiang Jiang,et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors , 2020, Nature.
[22] Bikash Medhi,et al. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) , 2020, Journal of biomolecular structure & dynamics.
[23] Rajat Kumar Jha,et al. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase , 2020, Journal of biomolecular structure & dynamics.
[24] M. Michael Gromiha,et al. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19 , 2020, Journal of biomolecular structure & dynamics.
[25] Ramakrishna Vadde,et al. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel , 2020, Journal of biomolecular structure & dynamics.
[26] Reaz Uddin,et al. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach , 2020, Journal of biomolecular structure & dynamics.
[27] Duong Tuan Quang,et al. Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil , 2020, ACS omega.
[28] A. Balkrishna,et al. Withanone from Withania somnifera May Inhibit Novel Coronavirus (COVID-19) Entry by Disrupting Interactions between Viral S-Protein Receptor Binding Domain and Host ACE2 Receptor , 2020 .
[29] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[30] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[31] Yechun Xu,et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors , 2020, bioRxiv.
[32] H. Juan,et al. Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking , 2020 .
[33] Wei Zhang,et al. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. , 2020, Bioscience trends.
[34] Federico M Giorgi,et al. Genomic variance of the 2019‐nCoV coronavirus , 2020, Journal of medical virology.
[35] A. Chaillon,et al. Transmission dynamics and evolutionary history of 2019‐nCoV , 2020, Journal of medical virology.
[36] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[37] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[38] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[39] Xiaomei Wang,et al. Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV , 2020, Journal of medical virology.
[40] G. Panayiotakopoulos,et al. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event , 2020, bioRxiv.
[41] M. Ciccozzi,et al. The 2019‐new coronavirus epidemic: Evidence for virus evolution , 2020, bioRxiv.
[42] Manoj-Kumar Gupta,et al. Insights into the structure–function relationship of both wild and mutant zinc transporter ZnT8 in human: a computational structural biology approach , 2020, Journal of biomolecular structure & dynamics.
[43] A. B. Tiku,et al. Radio-Modulatory Potential of Caffeic Acid Phenethyl Ester: A Therapeutic Perspective. , 2018, Anti-cancer agents in medicinal chemistry.
[44] K. Dhama,et al. Immunomodulatory and prophylactic efficacy of herbal extracts against experimentally induced chicken infectious anaemia in chicks: assessing the viral load and cell mediated immunity , 2017, VirusDisease.
[45] A. Koehler,et al. Activity of caffeic acid phenethyl ester in Caenorhabditis elegans. , 2016, Future medicinal chemistry.
[46] Haitao Yang,et al. Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design , 2016, Scientific Reports.
[47] Jennifer L. Knight,et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.
[48] H. K. Erdemli,et al. Antiviral properties of caffeic acid phenethyl ester and its potential application , 2015, Journal of intercultural ethnopharmacology.
[49] Zhi Cai,et al. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study , 2015, Cell Biochemistry and Biophysics.
[50] G. Murtaza,et al. Possible molecular targets for therapeutic applications of caffeic acid phenethyl ester in inflammation and cancer , 2014, Journal of food and drug analysis.
[51] N. Enomoto,et al. Inhibitory Effects of Caffeic Acid Phenethyl Ester Derivatives on Replication of Hepatitis C Virus , 2013, PloS one.
[52] Ralph S. Baric,et al. A decade after SARS: strategies for controlling emerging coronaviruses , 2013, Nature Reviews Microbiology.
[53] S. Akyol,et al. In Vivo and In Vitro Antıneoplastic Actions of Caffeic Acid Phenethyl Ester (CAPE): Therapeutic Perspectives , 2013, Nutrition and cancer.
[54] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[55] P. Wong,et al. Antiviral activity of four types of bioflavonoid against dengue virus type-2 , 2011, Virology Journal.
[56] Ramesh C. Gupta,et al. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. , 2011, Carcinogenesis.
[57] Susanna K. P. Lau,et al. Coronavirus Genomics and Bioinformatics Analysis , 2010, Viruses.
[58] David Calkins,et al. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution , 2010, J. Comput. Aided Mol. Des..
[59] E. Clercq. Strategies in the design of antiviral drugs , 2010, Nature Reviews Drug Discovery.
[60] E. Murphy,et al. Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells , 2010, Virulence.
[61] Shanta M. Messerli,et al. CAPE (caffeic acid phenethyl ester)‐based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice , 2009, Phytotherapy research : PTR.
[62] Federico D. Sacerdoti,et al. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters , 2006, ACM/IEEE SC 2006 Conference (SC'06).
[63] Matthew P. Repasky,et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.
[64] K. Mochida,et al. In Vitro Antibacterial, Antimutagenic and Anti-Influenza Virus Activity of Caffeic Acid Phenethyl Esters , 2005 .
[65] S. Lyu,et al. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2)in vitro , 2005, Archives of pharmacal research.
[66] Chao-Chin Hu,et al. Effects of CAPE-like compounds on HIV replication in vitro and modulation of cytokines in vivo. , 2005, The Journal of antimicrobial chemotherapy.
[67] Samson S. Y. Wong,et al. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia , 2005, Journal of Virology.
[68] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[69] B. Berkhout,et al. Identification of a new human coronavirus , 2004, Nature Medicine.
[70] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[71] Matthew P. Repasky,et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.
[72] M. Artico,et al. 2,6-Bis(3,4,5-trihydroxybenzylydene) derivatives of cyclohexanone: novel potent HIV-1 integrase inhibitors that prevent HIV-1 multiplication in cell-based assays. , 2004, Bioorganic & medicinal chemistry.
[73] Z. Su,et al. Caffeic acid phenethyl ester profoundly modifies protein synthesis profile in type 5 adenovirus-transformed cloned rat embryo fibroblast cells. , 1997, International journal of oncology.
[74] J. Boustie,et al. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. , 1994, Journal of natural products.
[75] O. Mirzoeva,et al. Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties , 1993, FEBS letters.
[76] K. Kohn,et al. Inhibitors of human immunodeficiency virus integrase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[77] J. Serkedjieva,et al. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). , 1992, Journal of natural products.
[78] C. E.. WHO Coronavirus Disease (COVID-19) Dashboard , 2020 .
[79] S. Kaul,et al. Science of Ashwagandha: Preventive and Therapeutic Potentials , 2017, Springer International Publishing.
[80] A. Naim. Caffeic acid phenethyl , 2009 .
[81] H B Broughton,et al. Molecular modeling. , 2020, Current opinion in chemical biology.